Tumor suppressor function can be modulated by subtle variation of expression levels, proper cellular compartmentalization and post-translational modifications, such as phosphorylation, acetylation and sumoylation. The non-genomic loss of function of tumor suppressors offers a challenging therapeutic opportunity. The reactivation of a tumor suppressor could indeed promote selective apoptosis of cancer cells without affecting normal cells. The identification of mechanisms that affect tumor suppressor functions is therefore essential. In this work, we show that BCR-ABL promotes the accumulation of the NFKBIA gene product, IκBa, in the cytosol through physical interaction and stabilization of the protein. Furthermore, BCR-ABL/IκBa complex acts as a scaffold protein favoring p53 nuclear exclusion. We therefore identify a novel BCR-ABL/IκBa/p53 network, whereby BCR-ABL functionally inactivates a key tumor suppressor.

Crivellaro, S., Panuzzo, C., Carrá, G., Volpengo, A., Crasto, F., Gottardi, E., et al. (2015). Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion. ONCOTARGET, 6(28), 25217-25225 [10.18632/oncotarget.4611].

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion

Piazza, R;Redaelli, S;
2015

Abstract

Tumor suppressor function can be modulated by subtle variation of expression levels, proper cellular compartmentalization and post-translational modifications, such as phosphorylation, acetylation and sumoylation. The non-genomic loss of function of tumor suppressors offers a challenging therapeutic opportunity. The reactivation of a tumor suppressor could indeed promote selective apoptosis of cancer cells without affecting normal cells. The identification of mechanisms that affect tumor suppressor functions is therefore essential. In this work, we show that BCR-ABL promotes the accumulation of the NFKBIA gene product, IκBa, in the cytosol through physical interaction and stabilization of the protein. Furthermore, BCR-ABL/IκBa complex acts as a scaffold protein favoring p53 nuclear exclusion. We therefore identify a novel BCR-ABL/IκBa/p53 network, whereby BCR-ABL functionally inactivates a key tumor suppressor.
Articolo in rivista - Articolo scientifico
Chronic myeloid leukemia; IκBa; NF-κB; P53; Tumor suppressor
English
2015
6
28
25217
25225
open
Crivellaro, S., Panuzzo, C., Carrá, G., Volpengo, A., Crasto, F., Gottardi, E., et al. (2015). Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion. ONCOTARGET, 6(28), 25217-25225 [10.18632/oncotarget.4611].
File in questo prodotto:
File Dimensione Formato  
10281-95123.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 5.87 MB
Formato Adobe PDF
5.87 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/95123
Citazioni
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
Social impact